TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biopart AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
23
|
51
|
346 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-28
|
5
|
37 |
| EBITDA |
-29
|
5
|
37 |
| Total assets |
99
|
153
|
203 |
| Current assets |
99
|
153
|
203 |
| Current liabilities |
37
|
8
|
43 |
| Equity capital |
62
|
140
|
147 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
62.6%
|
91.5%
|
72.4% |
| Turnover per employee |
23
|
51
|
173 |
| Profit as a percentage of turnover |
-121.7%
|
9.8%
|
10.7% |
| Return on assets (ROA) |
-28.3%
|
3.3%
|
18.2% |
| Current ratio |
267.6%
|
1912.5%
|
472.1% |
| Return on equity (ROE) |
-45.2%
|
3.6%
|
25.2% |
| Change turnover |
-28
|
-266
|
-154 |
| Change turnover % |
-55%
|
-84%
|
-31% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-50%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.